International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers

GM Mead, C Coppin, SP Stenning, Gedske Daugaard(Copenhagen University Hospital), Stuart Kaye(University of Wollongong), Giorgio Pizzocaro, Madhu Mazumdar(Memorial Sloan Kettering Cancer Center), J.P. Droz, Rtd Oliver, R. J. Sylvester, Penny A. Cook, VJ Harvey, Luis Paz‐Ares(Universidad Complutense de Madrid), A. Horwich(Institute of Cancer Research), J.A. Levi, A. Kramar, BM Colls, GJ Bosl, R deWit, R. J. Amato, Bajorin Df, S.D. Fosså, H. Cortés-Funes(Centre Hospitalier René-Dubos), CR Nichols, Phm deMulder, G. Stoter

UCL Discovery (University College London)

February 1, 1997

Cited by 1,036

Related Papers

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

|Journal of Clinical Oncology|2000|3.8k

An inflammatory cytokine signature predicts COVID-19 severity and survival

|Nature Medicine|2020|2.7k

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

|Journal of Clinical Oncology|1996|1.6k

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a<i>BRCA1</i>or<i>BRCA2</i>Gene Alteration

|Journal of Clinical Oncology|2020|676

Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer

|Journal of Clinical Oncology|2003|548